Veronica Byfield Sköld
Amministratore Delegato presso BioLamina AB
Posizioni attive di Veronica Byfield Sköld
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Amministratore Delegato | 01/10/2021 | - |
Direttore/Membro del Consiglio | 01/04/2021 | - |
Storia della carriera di Veronica Byfield Sköld
Precedenti posizioni note di Veronica Byfield Sköld
Società | Posizione | Inizio | Fine |
---|---|---|---|
CLEMONDO GROUP AB | Vendite & Marketing | 01/08/2020 | - |
Formazione di Veronica Byfield Sköld
Royal Institute of Technology | Graduate Degree |
IHM Business School AB | Undergraduate Degree |
Statistiche
Distribuzione geografica
Svezia | 5 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Graduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CLEMONDO GROUP AB | Consumer Non-Durables |
Aziende private | 1 |
---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |